Clinical trial for Stroke
Official title Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.
ClinicalTrials.gov ID: NCT06047782
What this study is testing
- What it's testing
- Atrial fibrillation is a cardiac arrhythmia most often originating in the left atrium, causing anarchic electrical activity and thus a loss of atrial contraction. This increases the risk of stroke through clot formation in the atrium, but also of heart failure.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient who has provided free, written and informed consent
- Patient of legal age
- Patient with cryptogenic ischemic stroke within 30 days of inclusion, documented by brain imaging (cerebral angioscan or cerebral MRI)
- Patients scheduled for implantable loop recorder implantation within 3 months of ischemic stroke in search of silent AF:
- cryptogenic ischemic stroke or stroke with probable cardioembolic cause
You likely can't join if
- Person not affiliated to national health insurance
- Person under legal protection (curatorship, guardianship)
- Person under court order
- Pregnant, parturient or breast-feeding
- Adult unable to give consent
- Patient diagnosed with AF during stroke assessment
See the full eligibility criteria
- Patient who has provided free, written and informed consent
- Patient of legal age
- Patient with cryptogenic ischemic stroke within 30 days of inclusion, documented by brain imaging (cerebral angioscan or cerebral MRI)
- Patients scheduled for implantable loop recorder implantation within 3 months of ischemic stroke in search of silent AF:
- cryptogenic ischemic stroke or stroke with probable cardioembolic cause
- no history of atrial fibrillation
- no long-term anticoagulant therapy
- with life expectancy \>12 months
- Person not affiliated to national health insurance
- Person under legal protection (curatorship, guardianship)
- Person under court order
- Pregnant, parturient or breast-feeding
- Adult unable to give consent
- Patient diagnosed with AF during stroke assessment
- Patient with a contraindication to MRI or gadolinium injection:
- Severe renal impairment (\<30ml/min Cockroft clearance due to gadolinium injection)
- Claustrophobia / contraindication to MRI (metal implant not MRI compatible)
- History of hypersensitivity to gadoteric acid or gadolinium-based contrast agents, and to meglumine
- Uncontrolled asthma
The study team makes the final eligibility decision.
Where it's taking place
- Dijon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.